Column

A cellulite-fighting drug is a big part of Malvern-based Endo’s plan to buy BioSpecifics for $658 million

Endo is paying a record price for BioSpecifics, a longtime supplier. And Endo shares rose on word of the deal.
Column

A cellulite-fighting drug is a big part of Malvern-based Endo’s plan to buy BioSpecifics for $658 million

Endo is paying a record price for BioSpecifics, a longtime supplier. And Endo shares rose on word of the deal.

Why some Pa. marijuana patients face jail for not surrendering their medical marijuana cards

The ACLU and critics says some judges are wrongly blocking holders of medical marijuana carts from drug court programs.

Why some Pa. marijuana patients face jail for not surrendering their medical marijuana cards

The ACLU and critics says some judges are wrongly blocking holders of medical marijuana carts from drug court programs.

Column

Philly-based GoPuff, the Wawa on wheels, raises $380 million more, says it’s worth nearly $4 billion

GoPuff, the Philly-based delivery service, raises another fortune, this time from Silicon Valley, making it a rare “unicorn" among Philadelphia-area start-ups.
Column

Philly-based GoPuff, the Wawa on wheels, raises $380 million more, says it’s worth nearly $4 billion

GoPuff, the Philly-based delivery service, raises another fortune, this time from Silicon Valley, making it a rare “unicorn" among Philadelphia-area start-ups.
More Stories

Immunome IPO on target as investors bet big on gene, cell therapies

Immunome is the latest pre-product, pre-profit biotech to go public with an IPO.

Moderna’s coronavirus vaccine won’t be ready for the public until the spring, its CEO says

Three other vaccine candidates are in the final stages of testing in the United States, though one of them has been paused.

Column

Radnor firm — with a product heroin makers rely on — stops key sales in Mexico

The Main Line-based based company started by ex-Rohm and Haas boss and corporate-governance thinker Rajiv L. Gupta, was a favored, if inadvertent, chemical supplier to Mexico's illegal heroin labs

AstraZeneca’s setback delivers reality check on vaccine risks

One of the most promising coronavirus vaccines has stumbled, delivering a reality check about the odds of clinical development and the safety risks involved.

Rather than give away its COVID-19 vaccine, Oxford makes a deal with drugmaker

In the U.S. and other developed nations, the solution to the reluctance of drug companies to create vaccines was to shower them with billions of dollars in public funds to persuade them to help.

New to medical marijuana? Curious? Here’s what experts say you should know.

Too much of a good thing can lead to serious confusion — and we're not just talking dosage. The number of product choices in Pennsylvania dispensaries can be overwhelming. Here's how to start.

FSD Pharma’s medical marijuana dreams go up in smoke

The company will focus on an anti-inflammatory drug its CEO said will treat COVID-19 patients.

FDA calls for removal of fruity, disposable e-cigarettes

U.S. health officials are cracking down on fruity disposable electronic cigarettes that are popular with teenagers.

FDA grants emergency approval to Quest COVID-19 test for ‘pooled’ sample use

The Food and Drug Administration has given emergency approval to Quest Diagnostics to use a new approach to coronavirus testing that combines test samples in batches instead of running them one by one, speeding up the process. It is the first test to be authorized to be used in this way.

Column

Philly brain-cancer vaccine developer tied to Jefferson raises $112 million

“We had four people last September. We have 12 now. We expect twice as many next summer.”

Coronavirus could be the turning point for a vaccine technology 30 years in the making

The coronavirus is rekindling excitement about genetic vaccine technology, even though it has yet to yield an approved immunization.

Bayer to pay up to $10.9 billion to settle Roundup weedkiller case

The German pharmaceutical company is settling a lawsuit over subsidiary Monsanto’s weedkiller Roundup, which has faced numerous lawsuits over claims it causes cancer.

SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.